Baystate Wealth Management LLC Biogen Inc. Transaction History

Baystate Wealth Management LLC

$1.36 Billion
Q4 2023

A detailed history of Baystate Wealth Management LLC transactions in Biogen Inc. stock. As of the latest transaction made, Baystate Wealth Management LLC holds 964 shares of BIIB stock, worth $219,859. This represents 0.02% of its overall portfolio holdings.

Number of Shares

964

Previous 984 2.03%

Holding current value

$219,859

Previous $252,000 1.19%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	SELL	$222.59 - $267.94 $4,451 - $5,358	-20 Reduced 2.03%	964 $249,000
Q3 2023 Oct 25, 2023	BUY	$253.3 - $285.89 $253 - $285	1 Added 0.1%	984 $252,000
Q2 2023 Sep 21, 2023	BUY	$275.25 - $318.06 $270,570 - $312,652	983 New	983 $280,000
Q4 2022 Jan 12, 2023	SELL	$252.44 - $306.72 $3,534 - $4,294	-14 Reduced 1.4%	983 $272,000
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $2,725 - $3,758	14 Added 1.42%	997 $266,000

Q1 2022 Apr 19, 2022	SELL	$193.77 - $244.14 $112,580 - $141,845	-581 Reduced 37.15%	983 $207,000
Q2 2021 Jul 26, 2021	SELL	$259.0 - $414.71 $139,083 - $222,699	-537 Reduced 25.56%	1,564 $542,000
Q4 2020 Jan 15, 2021	SELL	$236.26 - $355.63 $90,487 - $136,206	-383 Reduced 15.42%	2,101 $514,000
Q3 2020 Oct 14, 2020	BUY	$264.77 - $305.71 $264 - $305	1 Added 0.04%	2,484 $705,000
Q2 2020 Jul 28, 2020	SELL	$258.66 - $342.55 $29,745 - $39,393	-115 Reduced 4.43%	2,483 $665,000
Q1 2020 Apr 22, 2020	BUY	$268.85 - $341.04 $30,648 - $38,878	114 Added 4.59%	2,598 $822,000
Q4 2019 Jan 21, 2020	SELL	$220.06 - $304.07 $15,184 - $20,980	-69 Reduced 2.7%	2,484 $737,000
Q3 2019 Oct 30, 2019	SELL	$217.44 - $243.88 $4,131 - $4,633	-19 Reduced 0.74%	2,553 $594,000
Q2 2019 Jul 02, 2019	SELL	$219.29 - $241.72 $3,289 - $3,625	-15 Reduced 0.58%	2,572 $606,000
Q1 2019 Apr 25, 2019	BUY	$216.71 - $338.96 $3,250 - $5,084	15 Added 0.58%	2,587 $581,000
Q3 2018 Oct 16, 2018	SELL	$293.51 - $383.83 $293 - $383	-1 Reduced 0.04%	2,572 $868,000
Q2 2018 Jul 17, 2018	BUY	$257.52 - $306.91 $114,081 - $135,961	443 Added 20.8%	2,573 $885,000
Q1 2018 Apr 24, 2018	BUY	$260.13 - $367.91 $160,500 - $227,000	617 Added 40.78%	2,130 $552,000
Q3 2017 Oct 10, 2017	BUY	$281.15 - $329.69 $425,379 - $498,820	1,513	1,513 $498,000

Others Institutions Holding BIIB

# of Institutions

1,047

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baystate Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baystate Wealth Management LLC with notifications on news.

Account

Baystate Wealth Management LLC Biogen Inc. Transaction History